Dr. Mark Agulnik
Claim this profileCity of Hope
Expert in Soft Tissue Sarcoma
Studies Cancer
23 reported clinical trials
34 drugs studied
About Mark Agulnik
Education:
- Earned an MD from McGill University, Canada, in 1998.
Experience:
- Completed Internal Medicine Residency at Dalhousie University (1999-2001) and a Fellowship in Hematology & Oncology at the University of Illinois Medical Center (2002-2004).
- Over 15 years of service at Northwestern University Feinberg School of Medicine, specializing in sarcomas, head and neck cancer, bone cancer, and soft tissue cancers.
- Joined City of Hope in 2020, contributing significantly as a clinician, educator, and researcher.
- Recognized with multiple awards for his contributions to oncology.
Area of expertise
1Soft Tissue Sarcoma
Global LeaderStage IV
Stage III
p16 positive
2Cancer
Stage IV
Stage III
TSC1 positive
Affiliated Hospitals
Clinical Trials Mark Agulnik is currently running
INBRX-109
for Solid Tumors
This trial tests INBRX-109, a protein that attaches to harmful cells and signals the body to destroy them. It targets patients with conditions involving DR5, like certain cancers.
Recruiting1 award Phase 12 criteria
Adoptive Cell Therapy
for Cancer
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
Recruiting1 award Phase 1
More about Mark Agulnik
Clinical Trial Related3 years of experience running clinical trials · Led 23 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Mark Agulnik has experience with
- Placebo
- Doxorubicin
- Temozolomide
- Cemiplimab
- BI 907828
- SQ3370
Breakdown of trials Mark Agulnik has run
Soft Tissue Sarcoma
Cancer
Synovial Sarcoma
Liposarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Agulnik specialize in?
Mark Agulnik focuses on Soft Tissue Sarcoma and Cancer. In particular, much of their work with Soft Tissue Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Mark Agulnik currently recruiting for clinical trials?
Yes, Mark Agulnik is currently recruiting for 3 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Mark Agulnik has studied deeply?
Yes, Mark Agulnik has studied treatments such as Placebo, Doxorubicin, Temozolomide.
What is the best way to schedule an appointment with Mark Agulnik?
Apply for one of the trials that Mark Agulnik is conducting.
What is the office address of Mark Agulnik?
The office of Mark Agulnik is located at: City of Hope, Duarte, California 91010 United States. This is the address for their practice at the City of Hope.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.